Page 130 - GPD-3-3

Gene & Protein in Disease Hydrogen sulfide ameliorates NAFLD

45. Dugbartey GJ, Alornyo KK, Adams I, et al. Targeting transcriptome signatures in patients with varying degrees
hepatic sulfane sulfur/hydrogen sulfide signaling pathway of nonalcoholic fatty liver disease compared with healthy
with α-lipoic acid to prevent diabetes-induced liver injury normal-weight individuals. Am J Physiol Gastrointest Liver
via upregulating hepatic CSE/3-MST expression. Diabetol Physiol. 2019;316(4):G462-G472.
Metab Syndr. 2022;14(1):148. doi: 10.1152/ajpgi.00358.2018
doi: 10.1186/s13098-022-00921-x 50. Zeng J, Zhu B, Su M. Autophagy is involved in acetylshikonin
46. Matsumoto M, Hada N, Sakamaki Y, et al. An improved ameliorating non-alcoholic steatohepatitis through
mouse model that rapidly develops fibrosis in non-alcoholic AMPK/mTOR pathway. Biochem Biophys Res Commun.
steatohepatitis. Int J Exp Pathol. 2013;94:93-103. 2018;503(3):1645-1650.
doi: 10.1111/iep.12008 doi: 10.1016/j.bbrc.2018.07.094
47. Shen WJ, Azhar S, Kraemer FB. Lipid droplets and 51. Lai SL, Mustafa MR, Wong PF. Panduratin A induces
steroidogenic cells. Exp Cell Res. 2016;340(2):209-214. protective autophagy in melanoma via the AMPK and
mTOR pathway. Phytomedicine. 2018;42:144-151.
doi: 10.1016/j.yexcr.2015.11.024
doi: 10.1016/j.phymed.2018.03.027
48. Byrne CD, Targher G. NAFLD: A multisystem disease.
J Hepatol. 2015;62:S47-S64. 52. Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E.
Lysosomal turnover, but not a cellular level, of endogenous
doi: 10.1177/20420188221145549 LC3 is a marker for autophagy. Autophagy. 2005;1:84-91.
49. Suppli MP, Rigbolt KT, Veidal SS, et al. Hepatic doi: 10.4161/auto.1.2.1697

Volume 3 Issue 3 (2024) 12 doi: 10.36922/gpd.3409